C4 Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

C4 테라퓨틱스NASDAQ:CCCC · Nasdaq · Healthcare

$2.99+1.36%

2026-10-05 close · prelim

C4 Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $36M. 2024 operating profit was −$120M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy